PAPER Dringenberg HC, Laporte PP, Diavolitsis P
SEARCH RESULTS
332188 RESULTS
PAPER Halimi G, Duplan L, Bideau C, Iniesta D, Berthézène P, Oddoze C, Verdier JM, Michel B, Bergé-Lefranc JL
Association of APOE promoter but not A2M polymorphisms with risk of developing Alzheimer's disease.
Neuroreport. 2000 Nov 9;11(16):3599-601. PubMed: 11095526PAPER Lau KF, McLoughlin DM, Standen CL, Irving NG, Miller CC
Fe65 and X11beta co-localize with and compete for binding to the amyloid precursor protein.
Neuroreport. 2000 Nov 9;11(16):3607-10. PubMed: 11095528PAPER Farlow M, Anand R, Messina J, Hartman R, Veach J
A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease.
Eur Neurol. 2000;44(4):236-41. PubMed: 11096224PAPER Mokliatchouk O, Blacker D, Rabinowitz D
Association tests for traits with variable age at onset.
Hum Hered. 2001;51(1-2):46-53. PubMed: 11096271PAPER Kittler L, Wollweber L
Down-regulation of H tau 40 protein expression by minor groove binders.
Nucleosides Nucleotides Nucleic Acids. 2000 Aug;19(8):1241-8. PubMed: 11097054PAPER Gauthier E, Fortier I, Courchesne F, Pepin P, Mortimer J, Gauvreau D
Aluminum forms in drinking water and risk of Alzheimer's disease.
Environ Res. 2000 Nov;84(3):234-46. PubMed: 11097797PAPER Adamec E, Mohan PS, Cataldo AM, Vonsattel JP, Nixon RA
Up-regulation of the lysosomal system in experimental models of neuronal injury: implications for Alzheimer's disease.
Neuroscience. 2000;100(3):663-75. PubMed: 11098128PAPER Amouyal-Barkate K, Bagheri-Charabiani H, Montastruc JL, Moulias S, Vellas B
Abnormal movements with donepezil in Alzheimer disease.
Ann Pharmacother. 2000 Nov;34(11):1347. PubMed: 11098352PAPER Lee JM
Alzheimer disease
Arch Pathol Lab Med. 2000 Dec;124(12):1851. PubMed: 11100078PAPER Camps P, El Achab R, Morral J, Muñoz-Torrero D, Badia A, Baños JE, Vivas NM, Barril X, Orozco M, Luque FJ
New tacrine-huperzine A hybrids (huprines): highly potent tight-binding acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's disease.
J Med Chem. 2000 Nov 30;43(24):4657-66. PubMed: 11101357PAPER Singleton AB, Hall R, Ballard CG, Perry RH, Xuereb JH, Rubinsztein DC, Tysoe C, Matthews P, Cordell B, Kumar-Singh S, De Jonghe C, Cruts M, Van Broeckhoven C, Morris CM
Pathology of early-onset Alzheimer's disease cases bearing the Thr113-114ins presenilin-1 mutation.
Brain. 2000 Dec;123 Pt 12:2467-74. PubMed: 11099448PAPER Haugabook SJ, Le T, Yager D, Zenk B, Healy BM, Eckman EA, Prada C, Younkin L, Murphy P, Pinnix I, Onstead L, Sambamurti K, Golde TE, Dickson D, Younkin SG, Eckman CB
Reduction of Abeta accumulation in the Tg2576 animal model of Alzheimer's disease after oral administration of the phosphatidyl-inositol kinase inhibitor wortmannin.
FASEB J. 2001 Jan;15(1):16-18. Epub 2000 Nov 9 PubMed: 11099491PAPER Hu CJ, Sung SM, Liu HC, Hsu WC, Lee LS, Lee CC, Tsai CH, Chang JG
Genetic risk factors of sporadic Alzheimer's disease among Chinese in Taiwan.
J Neurol Sci. 2000 Dec 1;181(1-2):127-31. PubMed: 11099722PAPER Labar KS, Mesulam M, Gitelman DR, Weintraub S
Emotional curiosity: modulation of visuospatial attention by arousal is preserved in aging and early-stage Alzheimer's disease.
Neuropsychologia. 2000;38(13):1734-40. PubMed: 11099731Current Filters
No filters selected